The objective of this study was to determine if there is a change in femoral and tibial tunnel width and area from post-operative week 1 to post-operative month 6 between patients who have undergone ACL reconstruction with demineralized bone matrix (DBM, StimuBlast) and platelet-rich plasma (PRP) to patients who underwent ACL reconstruction alone.

Presented at:

American Orthopaedic Society for Sports Medicine (AOSSM) Biologics Workshop 2012, Baltimore MD